Latest news with #BlueMatter
Yahoo
04-08-2025
- Business
- Yahoo
Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement
-- Heinley to focus on strategic growth, and joins the leadership team of Sam Brown, a Blue Matter Company -- WAYNE, Pa. & NEW YORK, August 04, 2025--(BUSINESS WIRE)--Sam Brown Healthcare Communications, a Blue Matter Company, is proud to announce the appointment of Michael Heinley to the new position of Managing Director, Client Development and Engagement, reporting to Founder and President Laura Liotta. With deep in-house and agency PR experience in the life sciences industry, Heinley is a highly seasoned counselor with a proven record of strategic communications impact across leading global organizations. These include senior leadership roles at Johnson & Johnson, Merck & Co., Inc., and WebMD. Most recently, as Senior Partner in the Finn Partners Global Health Practice, he led client development and engagement for pharmaceutical, biotech, health tech, med tech, health systems, professional societies, and advocacy organizations. "In today's fast-moving and complex healthcare environment, Michael has a distinct perspective leading corporate, scientific, marketing, and brand storytelling campaigns that build trust, strengthen reputation, and deliver meaningful business results," said Laura Liotta, Founder and President of Sam Brown. "In this new role at Sam Brown, Michael will be instrumental in delivering innovative solutions, expanding our services and markets globally, and enabling our integrated teams to help clients adapt and lead in an evolving landscape." Throughout his career, Heinley oversaw multiple global pharmaceutical product launches, R&D communications, employee engagement, financial/IR communications, reputation and issues management, CEO and C-suite counsel, and executive thought leadership. Heinley was named among the industry's most influential leaders and Mentor of the Year by PM360. He currently serves on the Board of Directors for Donate Life New York State, a statewide nonprofit dedicated to increasing organ and tissue donation. "I'm thrilled to join the talented team at Sam Brown to help drive the agency's continued growth and success," said Heinley. "Under Laura's leadership, I've deeply admired the 'Sam Brownie' culture—recognized for building and sustaining enduring client partnerships through strategic expertise, hands-on senior counsel, and integrated creative excellence." About Sam Brown Healthcare Communications For 26 years, Sam Brown has been a leading healthcare-focused corporate, clinical, and commercial communications agency for the life sciences industry. Sam Brown provides broad strategic communications services to a wide range of biotechnology, biopharmaceutical, and venture capital companies whose cutting-edge science and innovation impact human health. For more information, visit About Blue Matter Blue Matter is a strategic consulting firm serving the life sciences industry. From its offices in North America, Europe and Asia, Blue Matter serves pharmaceutical and biotech companies from around the globe. The firm helps clients maximize value at the product, portfolio, and organization levels. It has broad therapeutic expertise with a focus on complex markets such as oncology, CNS, and rare diseases. For more information, visit View source version on Contacts Media Contact: Christy CurranSam Brown Inc.615.414.8668christycurran@ Sign in to access your portfolio


Business Wire
04-08-2025
- Business
- Business Wire
Michael Heinley Joins Sam Brown Healthcare Communications As
WAYNE, Pa. & NEW YORK--(BUSINESS WIRE)--Sam Brown Healthcare Communications, a Blue Matter Company, is proud to announce the appointment of Michael Heinley to the new position of Managing Director, Client Development and Engagement, reporting to Founder and President Laura Liotta. With deep in-house and agency PR experience in the life sciences industry, Heinley is a highly seasoned counselor with a proven record of strategic communications impact across leading global organizations. These include senior leadership roles at Johnson & Johnson, Merck & Co., Inc., and WebMD. Most recently, as Senior Partner in the Finn Partners Global Health Practice, he led client development and engagement for pharmaceutical, biotech, health tech, med tech, health systems, professional societies, and advocacy organizations. 'In today's fast-moving and complex healthcare environment, Michael has a distinct perspective leading corporate, scientific, marketing, and brand storytelling campaigns that build trust, strengthen reputation, and deliver meaningful business results,' said Laura Liotta, Founder and President of Sam Brown. 'In this new role at Sam Brown, Michael will be instrumental in delivering innovative solutions, expanding our services and markets globally, and enabling our integrated teams to help clients adapt and lead in an evolving landscape.' Throughout his career, Heinley oversaw multiple global pharmaceutical product launches, R&D communications, employee engagement, financial/IR communications, reputation and issues management, CEO and C-suite counsel, and executive thought leadership. Heinley was named among the industry's most influential leaders and Mentor of the Year by PM360. He currently serves on the Board of Directors for Donate Life New York State, a statewide nonprofit dedicated to increasing organ and tissue donation. 'I'm thrilled to join the talented team at Sam Brown to help drive the agency's continued growth and success,' said Heinley. 'Under Laura's leadership, I've deeply admired the 'Sam Brownie' culture—recognized for building and sustaining enduring client partnerships through strategic expertise, hands-on senior counsel, and integrated creative excellence.' About Sam Brown Healthcare Communications For 26 years, Sam Brown has been a leading healthcare-focused corporate, clinical, and commercial communications agency for the life sciences industry. Sam Brown provides broad strategic communications services to a wide range of biotechnology, biopharmaceutical, and venture capital companies whose cutting-edge science and innovation impact human health. For more information, visit About Blue Matter Blue Matter is a strategic consulting firm serving the life sciences industry. From its offices in North America, Europe and Asia, Blue Matter serves pharmaceutical and biotech companies from around the globe. The firm helps clients maximize value at the product, portfolio, and organization levels. It has broad therapeutic expertise with a focus on complex markets such as oncology, CNS, and rare diseases. For more information, visit


Business Wire
06-05-2025
- Business
- Business Wire
Blue Matter Hires New Partner, Jenna Riffell, Strengthening Capabilities in Europe
LONDON--(BUSINESS WIRE)--Blue Matter is pleased to announce that Jenna Riffell has joined as a Partner based in London. Jenna officially joined the firm on April 15 and brings a broad base of consulting experience that will strengthen the firm's capabilities across Europe. Prior to becoming a part of the Blue Matter team, Ms. Riffell spent nearly 10 years serving biopharmaceutical clients as a strategic consultant and leader with Kx Advisors. While there, she advanced through the consulting ranks to become a Managing Partner, building and leading Kx Advisors' European business. While Jenna has significant expertise in the business aspects of life sciences, she also brings a robust scientific background. Before launching her consulting career, she conducted scientific research in drug development at the University of British Columbia and The Institute of Cancer Research. Blue Matter Managing Partner, George Schmidt, said, 'Jenna brings a uniquely well-rounded background and deep expertise across areas that are critical to our clients' success. Her work spans corporate and franchise strategy, new product planning, commercial and launch strategy, and more—covering essential segments of the biopharma value chain. She also stands out as a people leader, known for mentoring teams and fostering a collaborative, high-performing environment.' Her work experience also encompasses multiple therapeutic spaces, with key focus areas being immunology, neurology, rare diseases, oncology, and women's health. Jenna added, 'I'm excited to become a part of the Blue Matter team and begin collaborating with clients across Europe and beyond. I've been impressed by the culture at Blue Matter, which focuses on excellence but also places tremendous emphasis on building high-functioning, high-morale teams. That dynamic is a unique aspect of the firm.' Jenna's educational background includes a Ph.D. in Biochemistry and Molecular Biology, as well as a (Hons) in Chemistry and Biochemistry, from the University of British Columbia. About Blue Matter Blue Matter ( is a strategic consulting firm serving the life sciences industry. From its offices in North America, Europe and Asia, Blue Matter serves pharmaceutical and biotech companies around the globe. The firm helps clients maximize value at the product, portfolio, and organization levels with a focus on corporate and product strategy in complex markets, as well as organizational effectiveness.